Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06681662
PHASE4

Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients

Sponsor: Matias Vested

View on ClinicalTrials.gov

Summary

The aim of this study is to determine the onset time of rocuronium after administration of ephedrine 0.15 mg/kg in patients with age ≥ 80 years. The hypothesis of this study is that ephedrine 0.15 mg/kg provides a shorter onset time compared to placebo (saline).

Official title: A Blinded Randomized Study of Ephedrine 0.15 Mg/kg for Reducing Onset Time of Rocuronium 0.6 Mg/kg in Elderly Patients (≥ 80 Years)

Key Details

Gender

All

Age Range

80 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-01-13

Completion Date

2025-12

Last Updated

2025-01-17

Healthy Volunteers

No

Interventions

DRUG

Ephedrine Hydrochloride 30 mg/ml

0.15 mg/kg during induction.

DRUG

Saline (NaCl 0,9 %) (placebo)

1 ml during induction.

Locations (2)

Department of Anaesthesiology, Pain and Respiratory Support, Rigshospitalet Glostrup

Copenhagen, Denmark

Department of Anesthesia, Centre of Head and Orthopedics, 6013 Rigshospitalet

Copenhagen, Denmark